Painreform Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative treatments for pain management

The company specializes in creating advanced formulations of cannabinoids, aiming to improve the effectiveness and safety of pain relief therapies for patients suffering from various chronic pain conditions. By leveraging cutting-edge research and development, Painreform strives to provide targeted solutions for pain alleviation, thereby enhancing the quality of life for patients while navigating the evolving landscape of pain management options.